C-MER Healthcare reports narrowed losses, recommends dividend

C-MER Medical Holdings Limited (HKEX: 3309) reported a net loss of HKD 108.3 million for the year ended December 31, 2024, a significant narrowing from the previous year's profit of HKD 86.3 million. Despite the loss, the board recommended a final dividend of HKD 0.02 per share, subject to shareholder approval at the annual general meeting scheduled for May 19, 2025. Adjusted profit attributable to equity holders increased by 5.7% year-over-year to HKD 58.7 million. Core medical service revenue rose 0.5% to HKD 1,913.2 million. The company experienced an impairment loss on non-cash items valued at HKD 182.7 million, along with gains from ceasing COVID-19 consumable sales which were restricted. In Mainland China, dental revenue increased by 18.5% to HKD 507.3 million. As for their outlook, the company is planning to capture the increase in cross-border consumption and promote medical integration between Shenzhen and Hong Kong.